Rejection of drug a blow for Australians living with Alzheimer’s disease
LISTEN TO PODCAST NOW
Podcast: Play in new window | Download (Duration: 9:45 — 13.4MB)
Subscribe or Follow Us: Apple Podcasts | Spotify | RSS
A new treatment for people living with the early stages of Alzheimer’s disease or mild cognitive impairment has been rejected by the Therapeutic Goods Administration (TGA).
With Dementia becoming the leading cause of death in Australia, it’s disappointing news for those impacted by Alzheimers.
Guest: Dr Kaele Stokes is Dementia Australia’s Executive Director – Services, Advocacy & Research.
Presenter: Warren Andrew.
Podcast: Play in new window | Download (Duration: 9:45 — 13.4MB)
Subscribe or Follow Us: Apple Podcasts | Spotify | RSS
RECENT PODCAST
Professor Jennifer McKay: Could you accidentally sign a contract by texting an emoji?
Can a thumbs-up emoji lock you into a legal contract? Professor Jennifer McKay AM, expert in business law and ...
LISTEN TO PODCAST NOW
Podcast: Play in new window | Download ()
Subscribe or Follow Us: Apple Podcasts | Spotify | RSS
Associate Professor Lauren Rosewarne: Relationships without conflict
George and Amal Clooney say they have never argued in their nearly ten years of marriage. Is that relationship goals… ...
LISTEN TO PODCAST NOW
Podcast: Play in new window | Download ()
Subscribe or Follow Us: Apple Podcasts | Spotify | RSS
Noah Secomb: 2025 Australian Federal Election Update
Early voting is underway as we approach the final stretch of the 2025 Australian Federal Election campaign. Hear about the third ...
LISTEN TO PODCAST NOW
Podcast: Play in new window | Download ()
Subscribe or Follow Us: Apple Podcasts | Spotify | RSS
